Hany Elmariah, MD, discussed the safety profile of fedratinib and its evolving role in the post-transplant setting for patients with myeloproliferative neoplasms.

Life expectancy in western countries, once on a steady upward trajectory, has hit a worrying slowdown with obesity, poor diet ...

Fresh snow has arrived just in time for the Fresh Tracks 5K Snowshoe event, raising funds for metastatic breast cancer ...

The slowdown in life expectancy improvements... highlights the urgent need for stronger action on the root causes' ...

International Childhood Cancer Day (ICCD) is a global collaborative campaign that takes place every year on February 15 to raise awareness about childhood cancer and to express support for children ...

Basophilia at diagnosis of myeloproliferative neoplasms was associated with a more aggressive disease phenotype and poorer ...

Objectives According to the International Agency for Research on Cancer, styrene is probably carcinogenic for ...

Survivors of blood or marrow transplants (BMT) face a significantly higher risk of developing cutaneous malignant neoplasms, including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and ...

3 Graduate School of Public Health, St Luke’s International University, Tokyo, Japan Objective Current guidelines recommend long-term image-based surveillance for patients with low-risk intraductal ...

Please provide your email address to receive an email when new articles are posted on . The survey included new questions about seeking second opinions, self-advocacy and post-treatment follow-up ...

However, survivors are at risk of secondary neoplasms. Few studies on such secondary neoplasms have been conducted outside of Europe and the United States. The aim of this study was to evaluate the ...

But they most commonly manifest in headaches, fatigue, and dizziness among others. A myeloproliferative neoplasms (MPN) panel blood test is a group of tests that determines the shape, size, and number ...